P.12.12 Preclinical in vitro and in vivo evaluation of sodium channel blockers as possible alternative to mexiletine in the treatment of myotonia
Desaphy, J.F, Carbonara, R, Costanza, T, Lentini, G, Cavalluzzi, M.M, Franchini, C, Conte Camerino, D
Published in Neuromuscular disorders : NMD (01.10.2013)
Published in Neuromuscular disorders : NMD (01.10.2013)
Get full text
Journal Article
G.P.137
Imbrici, P, Desaphy, J.F, Brugnoni, R, Colleoni, L, Canioni, E, Kapetis, D, Altamura, C, Bernasconi, P, Morandi, L, Maggi, L, Mantegazza, R, Conte, D
Published in Neuromuscular disorders : NMD (01.10.2014)
Published in Neuromuscular disorders : NMD (01.10.2014)
Get full text
Journal Article
Safinamide effects on skeletal muscle sodium channels and models of non-dystrophic myotonia (NDM) compared to mexiletine: Exploring potential for clinical utility
Desaphy, J.F., De Bellis, M., Farinato, A., Altamura, C., Imbrici, P., Caccia, C., Melloni, E., Padoani, G., Vailati, S., Keywood, C., Conte, D., Pierno, S.
Published in Journal of the neurological sciences (15.10.2019)
Published in Journal of the neurological sciences (15.10.2019)
Get full text
Journal Article
G.P.137: Functional study of five new CLC-1 mutations causing myotonia congenita in Italian families
Imbrici, P., Desaphy, J.F., Brugnoni, R., Colleoni, L., Canioni, E., Kapetis, D., Altamura, C., Bernasconi, P., Morandi, L., Maggi, L., Mantegazza, R., Conte, D.
Published in Neuromuscular disorders : NMD (01.10.2014)
Published in Neuromuscular disorders : NMD (01.10.2014)
Get full text
Journal Article